Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 9
Original Research
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,744 | Dovepress* | 8,447+ | 1,685 | 10,132 | |
| PubMed Central* | 1,297 | 597 | 1,894 | ||
| Totals | 9,744 | 2,282 | 12,026 | ||
| *Since 25 October 2017 | |||||
View citations on PubMed Central and Google Scholar